Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5170)
All Articles published online
|
Publishing Process of This Article
|
Jul 27, 2022 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li XY, Ji PX, Ni XX, Chen YX, Sheng L, Lian M, Guo CJ, Hua J. Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1365-1381 [PMID: 36158922 DOI: 10.4254/wjh.v14.i7.1365] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i7/1365.htm |
| Number | Citing Articles |
| 1 |
Giovanni Musso, Francesca Saba, Maurizio Cassader, Roberto Gambino. Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances. Progress in Lipid Research 2023; 91: 101238 doi: 10.1016/j.plipres.2023.101238
|
| 2 |
Xiaoyan Qin, Zhengli Tan, Qi Li, Shiyi Zhang, Dingheng Hu, Denghui Wang, Liangxu Wang, Baoyong Zhou, Rui Liao, Zhongjun Wu, Yanyao Liu. Rosiglitazone attenuates Acute Kidney Injury from hepatic ischemia–reperfusion in mice by inhibiting arachidonic acid metabolism through the PPAR-γ/NF-κB pathway. Inflammation Research 2024; 73(10): 1765 doi: 10.1007/s00011-024-01929-x
|
| 3 |
Zhi-Chao Liu, Huan-Jie Fu, Ning-Cen Li, Fang-Jun Deng, Yong-Kang Gan, Yu-Jia Ye, Bing-Hui Huang, Chang Liu, Jin-Hong Chen, Xiao-Feng Li. Systematic pharmacology and experimental validation to elucidate the inflammation-associated mechanism of Huanglian Wendan (HLWD) decoction in the treatment of MAFLD associated with atherosclerosis. Journal of Ethnopharmacology 2025; 337: 118841 doi: 10.1016/j.jep.2024.118841
|
| 4 |
Hung Thai Vu, Vien Duc Nguyen, Hiroko Ikenaga, Tsutomu Matsubara. Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment. Biomedicines 2024; 12(8): 1876 doi: 10.3390/biomedicines12081876
|
| 5 |
Pei‐Xuan Ji, Yu‐Xin Chen, Xi‐Xi Ni, Qi Miao, Jing Hua. Effect of triggering receptor expressed on myeloid cells 2‐associated alterations on lipid metabolism in macrophages in the development of non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2024; 39(2): 369 doi: 10.1111/jgh.16417
|
| 6 |
A. N. Abd Halim, N. A. S. Zikri, Z. Ngaini, N. H. Zamakshshari, Y. K. Wei, D. Noissy Diosing. Synthesis In Silico and ADMET Profile of Triazinethione Derivatives for Their Potential as Anti-Inflammatory Agents. Russian Journal of General Chemistry 2023; 93(11): 2889 doi: 10.1134/S1070363223110208
|
| 7 |
Yingxin Tian, Yiming Ni, Ting Zhang, Yemin Cao, Mingmei Zhou, Cheng Zhao. Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1444198
|